Introduction. Glutathione synthetase deficiency (GSSD) is a rare autosomal recessive inborn error of metabolism characterized by impaired glutathione synthesis, leading to oxidative stress, hemolytic anemia, and severe metabolic acidosis. Neonatal presentation is often dramatic and associated with high morbidity and mortality.
Case presentation. We report the case of a term neonate who developed early-onset respiratory distress, severe high-anion gap metabolic acidosis, and progressive hemolytic anemia within the first 24 hours of life. Despite intensive supportive therapy, metabolic acidosis remained refractory. Extended metabolic investigations, including urinary 5-oxoproline analysis, could not be performed locally. Whole-genome sequencing confirmed the diagnosis of glutathione synthetase deficiency. Antioxidant therapy together with metabolic stabilization resulted in gradual clinical improvement.
Conclusions. This case highlights the importance of considering glutathione synthetase deficiency in newborns presenting with unexplained metabolic acidosis and hemolytic anemia. Early metabolic evaluation, genetic confirmation, and targeted antioxidant therapy may be lifesaving and improve neurological outcomes.
Keywords: glutathione synthetase deficiency, newborn, metabolic acidosis, hemolytic anemia, inborn errors of metabolism.
Case presentation. We report the case of a term neonate who developed early-onset respiratory distress, severe high-anion gap metabolic acidosis, and progressive hemolytic anemia within the first 24 hours of life. Despite intensive supportive therapy, metabolic acidosis remained refractory. Extended metabolic investigations, including urinary 5-oxoproline analysis, could not be performed locally. Whole-genome sequencing confirmed the diagnosis of glutathione synthetase deficiency. Antioxidant therapy together with metabolic stabilization resulted in gradual clinical improvement.
Conclusions. This case highlights the importance of considering glutathione synthetase deficiency in newborns presenting with unexplained metabolic acidosis and hemolytic anemia. Early metabolic evaluation, genetic confirmation, and targeted antioxidant therapy may be lifesaving and improve neurological outcomes.
Keywords: glutathione synthetase deficiency, newborn, metabolic acidosis, hemolytic anemia, inborn errors of metabolism.
Address for correspondence: Evelina KREKO
Neonatology Service, University Hospital of Obstetrics and Gynecology “Koço Gliozheni”, Tirana, Albania
Address: Bulevardi Bajram Curri, Tirana, Albania
E-mail address: evelinakreko@yahoo.com
Phone: +355673756184
Neonatology Service, University Hospital of Obstetrics and Gynecology “Koço Gliozheni”, Tirana, Albania
Address: Bulevardi Bajram Curri, Tirana, Albania
E-mail address: evelinakreko@yahoo.com
Phone: +355673756184
